Anticonvulsants

Charlotte's Web, Inc. to be Exclusive Hemp CBD Provider at Life Time

Retrieved on: 
Tuesday, June 29, 2021
Drugs, Anticonvulsants, Agriculture, Crops, Analgesics, Cannabidiol, Cannabinoids, Resorcinols, Charlotte's Web, Hemp, CBD

"This is a strategic relationship born of our shared valuesaround wellness, quality and sustainability," said Deanie Elsner,Charlotte's WebCEO and President.

Key Points: 
  • "This is a strategic relationship born of our shared valuesaround wellness, quality and sustainability," said Deanie Elsner,Charlotte's WebCEO and President.
  • "This partnership aligns well with our expansion strategy to reachconsumersin new environments across the U.S.We are excitedtowork with Life Time."
  • "Charlotte's Web is extremely well-respected in the CBD category and we are pleased to have them as our exclusive CBD retail partner."
  • Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Denver, Colorado, is the market leader in innovative hemp-derived cannabidiol ("CBD") wellness products under a family of brands which includes Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp.

Kadenwood Raises $50M to Accelerate Leadership Position in Shaping CBD Into Mainstream Wellness Category

Retrieved on: 
Tuesday, June 29, 2021
Drugs, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Wellness, Hemp, CBD

This latest funding round further accelerates the brand's mission to normalize CBD in health and wellness products.

Key Points: 
  • This latest funding round further accelerates the brand's mission to normalize CBD in health and wellness products.
  • In just the first half of 2021, Kadenwood has made a number of high-profile acquisitions, including CBD wellness brands Healist Advanced Naturals and Social CBD .
  • The deal effectively established Kadenwood as the largest supplier of vertically-integrated, hemp-derived cannabidiol (CBD) in the US, expanding the company's ability to scale production of its quality-driven CBD products.
  • Founded in 2019, Kadenwood is a privately held consumer products lifestyle company relentlessly focused on shaping CBD into a trusted and safe mainstream wellness category.

Medolife Rx Enters Partnership Agreement with Leading International Distributor, Brings Products to Mexico

Retrieved on: 
Tuesday, June 29, 2021
Drugs, Health care, Health sciences, Analgesics, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Medication, Over-the-counter drug

Products to be sold in Mexico through the agreement include Medolifes Immunapen product line, as well as its cannabidiol (CBD) and non-CBD line of pain relief/muscle creams.

Key Points: 
  • Products to be sold in Mexico through the agreement include Medolifes Immunapen product line, as well as its cannabidiol (CBD) and non-CBD line of pain relief/muscle creams.
  • Additionally, Medolife will use its patented polarization technology to enhance existing over-the-counter (OTC) pharmaceutical-grade white label products, such as male enhancement products and vitamins.
  • The first products to enter Mexico will be the CBD Muscle and Pain cream, with additional products following shortly, including tinctures and sprays.
  • Medolife Rx, Inc. is a global biotechnology company with operations in clinical research, manufacturing, and consumer products.

Global Cannabidiol Market (2021 to 2026) - by Source, Distribution Channel, Product, Route of Administration, End-user and Geography - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 24, 2021
Alternative medicine, Health, Retail, Tobacco, Pharmaceutical, Drugs, Cannabinoids, Analgesics, Anticonvulsants, Cannabidiol, Resorcinols, CBD

Changing regulatory landscape and legalization for approval of CBD-based products globally is also expected to propel the market growth.

Key Points: 
  • Changing regulatory landscape and legalization for approval of CBD-based products globally is also expected to propel the market growth.
  • However, the factor such as the high cost of CBD and barriers in its marketing hinders the market growth.
  • The absence of legalization programs in several Asian and African countries is also impeding the growth of the CBD market.
  • The Global Cannabidiol Market is segmented further based on Source, Distribution Channel, Product, Route of Administration, End-User, and Geography.

CBDfx Launches CBD-Infused Pet Balm As Pet CBD Industry Continues to Skyrocket

Retrieved on: 
Wednesday, June 23, 2021
Drugs, Articles, Philosophical theories, Analgesics, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Veganism

LOS ANGELES, June 23, 2021 /PRNewswire/ -- CBD industry giant, CBDfx , continues to broaden its wildly popular CBD pet line, announcing today the addition of a new all-natural Calming & Moisturizing CBD Pet Balm targeting problem areas, such as paw pads and noses, to provide quick, concentrated relief and a boost of calm for pets.

Key Points: 
  • LOS ANGELES, June 23, 2021 /PRNewswire/ -- CBD industry giant, CBDfx , continues to broaden its wildly popular CBD pet line, announcing today the addition of a new all-natural Calming & Moisturizing CBD Pet Balm targeting problem areas, such as paw pads and noses, to provide quick, concentrated relief and a boost of calm for pets.
  • CBDfx's all-natural Calming & Moisturizing CBD Pet Balm provides quick, concentrated relief and a boost of calm for pets
    Consumers spent $426 million on Pet CBD in 2020 and are expected to reach $629 million in sales by the end of 2021, according to industry researcher, Brightfield Group, whose reports show that Pet CBD is more than a passing fad.
  • The Calming & Moisturizing CBD Pet Balm joins CBDfx's vegan Pet Treats in two variations targeting anxiety and joint health, and their full line of vegan CBD Oil for Pets.
  • Founded in 2014 with a mission to push quality to the forefront of the CBD industry, CBDfx continues to provide some of the finest, purest, and most effective CBD products in the world.

Tauriga Sciences, Inc. Appoints Colorado-based Orthopedic Surgeon, Dr. Craig Loucks, as Member of the Company’s Advisory Board

Retrieved on: 
Wednesday, June 23, 2021
Drugs, United States patent law, Analgesics, Anticonvulsants, Cannabidiol, Resorcinols, Patent, CBD, Provisional application, Loucks

Loucks is an accomplished orthopedic surgeon, based in Englewood, Colorado.Dr.

Key Points: 
  • Loucks is an accomplished orthopedic surgeon, based in Englewood, Colorado.Dr.
  • Loucks is a strong believer in Cannabidiol (CBD) based products and has pre-ordered the Companys enhanced 25mg CBD and CBG infused Tauri-Gum products.Dr.
  • Please visit our corporate website, for additional information, as well as inquiries, athttp://www.tauriga.com
    Complementary to the Companys retail business, is its ongoing Pharmaceutical Development initiative.
  • Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.The Patent, filed with the U.S.P.T.O.

Peer-Reviewed Scientific Publication Demonstrates Central Role of Neurotoxic Soluble Amyloid Oligomers in Driving Alzheimer’s Pathogenesis

Retrieved on: 
Wednesday, June 23, 2021
Research, Mental health, Genetics, Clinical trials, Other Health, Biotechnology, Pharmaceutical, Health, Science, Other Science, Branches of biology, Amyloidosis, Biology, Alzheimer's disease, Neuroscience, Monoclonal antibodies, Anticonvulsants, Homotaurine, Amyloid, Alzheon, Bapineuzumab, ALZ-801, Alzheon, ALZ-801, ALZHEON

This positions ALZ-801 to potentially become the first oral disease-modifying agent for patients and healthy people at high risk for Alzheimers disease.

Key Points: 
  • This positions ALZ-801 to potentially become the first oral disease-modifying agent for patients and healthy people at high risk for Alzheimers disease.
  • The publication provides an up-to-date summary of longitudinal clinical data elucidating the chronology of amyloid and tau biomarkers in AD, and review of non-clinical studies and clinical trials supporting the upstream pathogenic role of amyloid oligomers in AD.
  • Analyze data on clearance of amyloid plaques in amyloid antibody trials showing that even complete plaque removal does not correlate with clinical efficacy.
  • ALZ-801is an oral small molecule prodrug of tramiprosate that fully blocks formation of neurotoxic soluble amyloid oligomers in the brain.

Charlotte's Web Appoints Former Canopy Growth Executive, Tim Saunders, to Board of Directors

Retrieved on: 
Monday, June 21, 2021
Health sciences, Agriculture, Herbs, Medicinal plants, Medicine, Anticonvulsants, Charlotte's Web, Hemp, Canopy Growth, OTC Markets Group, Medical cannabis, Cannabis

DENVER, June 21, 2021 /PRNewswire/ -Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp CBD extract products , announced the appointment ofTim Saunders to its Board of Directors.

Key Points: 
  • DENVER, June 21, 2021 /PRNewswire/ -Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp CBD extract products , announced the appointment ofTim Saunders to its Board of Directors.
  • Tim Saunders was Chief Financial Officer of Canopy Growth Corporation ("Canopy") fromits entrepreneurial beginning and led its public up-listingtothe Toronto Stock Exchange, and subsequently tothe New York Stock Exchange both firsts for the cannabis sector.
  • Tim Saunders earned his CPA, CA with PricewaterhouseCoopers and is a graduate of Bishop's University where he obtained his BBA.
  • "Charlotte's Web has disclosed its intent to expand into Canada, Israel, Europe, and the U.K. where Tim has valuable strategic and regulatory insight.

CBDistillery™ Sets Aside Thousands Of Products To Advance The Efficacy of Hemp-Derived Wellness Products

Retrieved on: 
Thursday, June 17, 2021
Drugs, Psychoactive drugs, Entheogens, Euphoriants, Anticonvulsants, Cannabidiol, Cannabinoids, Hemp, Cannabis

CBDistillery is on a mission to be the premier educational resource and "one-stop-shop" for consumers curious about hemp-derived CBD, CBG, and CBN products.

Key Points: 
  • CBDistillery is on a mission to be the premier educational resource and "one-stop-shop" for consumers curious about hemp-derived CBD, CBG, and CBN products.
  • Eligible participants will receive two complimentary CBDistillery products - a 1000mg Isolate CBD Oil, and a 1000mg Broad Spectrum CBD Oil.
  • "At Balanced Health Botanicals, we're invested in bringing efficacy to hemp-derived wellness products through dynamic research-based partnerships.
  • CBDistillery was founded in 2016 with the belief that everyone deserves access to high quality, effective, and affordable CBD products.

Leading CBD and Wellness Brands Launch in the Caribbean and Central America

Retrieved on: 
Wednesday, June 16, 2021
Drugs, Analgesics, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, The WB, CBD

WB Canna Co. & Wellness is a wholly owned subsidiary of WEBB Banks, the leading premium wine and spirits distributor in the Caribbean and Central America, and travel retail in the Americas.

Key Points: 
  • WB Canna Co. & Wellness is a wholly owned subsidiary of WEBB Banks, the leading premium wine and spirits distributor in the Caribbean and Central America, and travel retail in the Americas.
  • "Looking at the rapid growth of CBD and wellness brands, I've never before seen that level of consumer enthusiasm for new brands and categories.
  • Its broader wellness portfolio, which excludes CBD products, will launch in all Caribbean, Central American, and duty free markets.
  • WB Canna Co. & Wellness, a wholly owned subsidiary ofMiami-based WEBB Banks, distributes top-quality cannabidiol (CBD) and wellness products in the Caribbean, Central America, and Travel Retail.